1. Home
  2. TMDE vs SNGX Comparison

TMDE vs SNGX Comparison

Compare TMDE & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TMDE

TMD Energy Limited Ordinary Shares

HOLD

Current Price

$0.48

Market Cap

16.2M

Sector

Energy

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.11

Market Cap

14.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDE
SNGX
Founded
2016
1987
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
14.4M
IPO Year
2025
1987

Fundamental Metrics

Financial Performance
Metric
TMDE
SNGX
Price
$0.48
$1.11
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
240.3K
180.1K
Earning Date
09-29-2025
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$607,422,733.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$1.09
52 Week High
$6.27
$6.23

Technical Indicators

Market Signals
Indicator
TMDE
SNGX
Relative Strength Index (RSI) 39.33 30.17
Support Level $0.54 $1.27
Resistance Level $0.63 $1.41
Average True Range (ATR) 0.07 0.08
MACD -0.02 -0.02
Stochastic Oscillator 14.22 1.39

Price Performance

Historical Comparison
TMDE
SNGX

About TMDE TMD Energy Limited Ordinary Shares

TMD Energy Ltd is engaged in marine fuel bunkering services specializing in the supply and marketing of marine gas oil and marine fuel oil (including high sulfur fuel oil, low sulfur fuel oil and very low sulfur fuel oil), to ships and vessels at sea. It is also involved in the provision of ship management services for in-house and external vessels, as well as vessel chartering. It is currently operating with a fleet of nearly 15 bunkering vessels ranging from 540 dwt to 7,820 dwt, of which nearly nine (9) are double bottom and double hull vessels with an average cargo-carrying capacity of approximately 4,200 dwt each.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: